Unibest

Pipeline Database

UB457

Azithromycin Oral Suspension

UB457

ProductAzithromycin Oral Suspension
Strength100mg/5mL: 15mL 200mg/5mL: 15mL, 22.5mL, 30mL
IndicationsUpper respiratory tract infection; Lower respiratory tract infection; Otitis media; Skin infection; Soft tissue infection
TherapeuticsInfectious Diseases
GMPUS - FDA
RegistrationUnited States
ModalitiesSmall Molecule

Exclusive Summary

  • - Patent barriers have expired; US registration enables a high-compliance source for rapid multi-country distribution.
  • - Large, recurring pediatric demand in respiratory and ear infections, with once-daily short-course dosing driving adherence and uptake.
  • - Pack sizes (200 mg/5 mL: 15/22.5/30 mL; 100 mg/5 mL: 15 mL) precisely match weight bands so one bottle completes the 30 mg/kg course, minimizing waste.
  • - Listed on the WHO EML/EMLc and recommended as first-line alternative in penicillin-allergic or atypical cases across guidelines, confirming its standard-of-care role.
  • - US registration/cGMP with CTD dossier plus 80–95% price discount vs originator supports competitive tendering and commercial distribution.

How can we help you?

Receive insights into the latest events and regulatory updates

Sent directly to your email

Get industry insights and Unibest news here

Contact Us →